查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386274

自体干细胞和非干细胞疗法市场报告：2030 年趋势、预测和竞争分析

Autologous Stem Cell and Non-Stem Cell Based Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

自体干细胞和非干细胞治疗趋势和预测

至2030年，全球自体干细胞和非干细胞治疗市场预计将达到130亿美元，2024年至2030年的年复合成长率为10.2%。该市场的主要驱动力是对微创治疗的需求不断增长、干细胞和非干细胞治疗方法的快速技术进步以及政府对促进再生医学应用的支持不断增加。全球自体干细胞和非干细胞治疗市场的未来前景广阔，医院和门诊手术中心市场充满机会。

自体干细胞与非干细胞治疗市场洞察

Lucintel 预测，由于癌症盛行率和治疗方法的扩大，以及自体干细胞治疗的使用不断增加，癌症和肿瘤学预计将在预测期内实现最高增长。

由于慢性病的高盛行率、对微创治疗的巨大需求以及有利的政府报销政策的存在，预计北美在预测期内将出现最高的增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球自体干细胞与非干细胞治疗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球自体干细胞和非干细胞治疗市场趋势（2018-2023）和预测（2024-2030）
  • 按产品类型分類的全球自体干细胞和非干细胞疗法市场
    • 血压监测装置
    • 肺压监测装置
    • 颅内压监测装置
  • 按类型分類的全球自体干细胞和非干细胞治疗市场
    • 自体干细胞
    • 自体非干细胞
  • 全球自体干细胞和非干细胞疗法市场（按应用）
    • 神经退化性疾病
    • 自体免疫疾病
    • 癌症和肿瘤
    • 心血管疾病
  • 按最终用途分類的全球自体干细胞和非干细胞治疗市场
    • 医院
    • 门诊手术中心
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球自体干细胞和非干细胞疗法市场（按地区）
  • 北美自体干细胞与非干细胞治疗市场
  • 欧洲自体干细胞与非干细胞治疗市场
  • 亚太地区自体干细胞与非干细胞治疗市场
  • 其他区域自体干细胞和非干细胞治疗市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球自体干细胞和非干细胞疗法市场成长机会（按产品类型）
    • 全球自体干细胞和非干细胞治疗市场成长机会（按类型）
    • 全球自体干细胞和非干细胞疗法市场成长机会（按应用）
    • 全球自体干细胞和非干细胞疗法市场的成长机会（以最终用途）
    • 全球自体干细胞和非干细胞疗法市场成长机会（按地区）
  • 全球自体干细胞和非干细胞治疗市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球自体干细胞和非干细胞疗法市场的产能
    • 全球自体干细胞和非干细胞治疗市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • BrainStorm Cell
  • Cytori Therapeutics
  • Dendreon Pharmaceuticals
  • Novartis
  • US Stem Cell
简介目录

Autologous Stem Cell and Non-Stem Cell Based Therapy Trends and Forecast

The future of the global autologous stem cell and non-stem cell based therapy market looks promising with opportunities in the hospital and ambulatory surgical center markets. The global autologous stem cell and non-stem cell based therapy market is expected to reach an estimated $13.0 billion by 2030 with a CAGR of 10.2% from 2024 to 2030. The major drivers for this market are growing demand for minimally invasive procedures, rapid technological advancements in stem cell and non-stem cell-based therapies, and rising supportive government initiatives to promote the use of regenerative medicine.

A more than 150-page report is developed to help in your business decisions.

Autologous Stem Cell and Non-Stem Cell Based Therapy by Segment

The study includes a forecast for the global autologous stem cell and non-stem cell based therapy by product type, type, application, end use, and region.

Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Blood Pressure Monitoring Devices
  • Pulmonary Pressure Monitoring Devices
  • Intracranial Pressure Monitoring Devices

Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Autologous Stem Cells
  • Autologous Non-Stem Cells

Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Neurodegenerative Disorders
  • Autoimmune Diseases
  • Cancer & Tumors
  • Cardiovascular Diseases

Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Autologous Stem Cell and Non-Stem Cell Based Therapy Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies autologous stem cell and non-stem cell based therapy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the autologous stem cell and non-stem cell based therapy companies profiled in this report include-

  • BrainStorm Cell
  • Cytori Therapeutics
  • Dendreon Pharmaceuticals
  • Novartis
  • U.S. Stem Cell

Autologous Stem Cell and Non-Stem Cell Based Therapy Market Insights

Lucintel forecasts that cancer & tumor is expected to witness highest growth over the forecast period due to the rising use of autologous therapy along with the expanding incidence of cancer cases and treatments.

North America is expected to witness highest growth over the forecast perioddue to the high prevalence of chronic diseases, existence of significant demand for minimally invasive procedures, and availability of favorable government reimbursement policies in the region.

Features of the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market

Market Size Estimates: Autologous stem cell and non-stem cell based therapy market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Autologous stem cell and non-stem cell based therapy market size by various segments, such as by product type, type, application, end use, and region in terms of ($B).

Regional Analysis: Autologous stem cell and non-stem cell based therapy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, types, applications, end uses, and regions for the autologous stem cell and non-stem cell based therapy market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the autologous stem cell and non-stem cell based therapy market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the autologous stem cell and non-stem cell based therapy market size?

Answer: The global autologous stem cell and non-stem cell based therapy market is expected to reach an estimated $13.0 billion by 2030.

Q.2 What is the growth forecast for autologous stem cell and non-stem cell based therapy market?

Answer: The global autologous stem cell and non-stem cell based therapy market is expected to grow with a CAGR of 10.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the autologous stem cell and non-stem cell based therapy market?

Answer: The major drivers for this market are growing demand for minimally invasive procedures, rapid technological advancements in stem cell and non-stem cell-based therapies, and rising supportive government initiatives to promote the use of regenerative medicine.

Q4. What are the major segments for autologous stem cell and non-stem cell based therapy market?

Answer: The future of the autologous stem cell and non-stem cell based therapy market looks promising with opportunities in the hospital and ambulatory surgical center markets.

Q5. Who are the key autologous stem cell and non-stem cell based therapy market companies?

Answer: Some of the key autologous stem cell and non-stem cell based therapy companies are as follows:

  • BrainStorm Cell
  • Cytori Therapeutics
  • Dendreon Pharmaceuticals
  • Novartis
  • U.S. Stem Cell

Q6. Which autologous stem cell and non-stem cell based therapy market segment will be the largest in future?

Answer: Lucintel forecasts that cancer & tumor is expected to witness highest growth over the forecast period due to the rising use of autologous therapy along with the expanding incidence of cancer cases and treatments.

Q7. In autologous stem cell and non-stem cell based therapy market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast perioddue to the high prevalence of chronic diseases, existence of significant demand for minimally invasive procedures, and availability of favorable government reimbursement policies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the autologous stem cell and non-stem cell based therapy market by product type (blood pressure monitoring devices, pulmonary pressure monitoring devices, and intracranial pressure monitoring devices), type (autologous stem cells and autologous non-stem cells), application (neurodegenerative disorders, autoimmune diseases, cancer & tumors, and cardiovascular diseases), end use (hospitals, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Product Type
    • 3.3.1: Blood Pressure Monitoring Devices
    • 3.3.2: Pulmonary Pressure Monitoring Devices
    • 3.3.3: Intracranial Pressure Monitoring Devices
  • 3.4: Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Type
    • 3.4.1: Autologous Stem Cells
    • 3.4.2: Autologous Non-Stem Cells
  • 3.5: Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application
    • 3.5.1: Neurodegenerative Disorders
    • 3.5.2: Autoimmune Diseases
    • 3.5.3: Cancer & Tumors
    • 3.5.4: Cardiovascular Diseases
  • 3.6: Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Ambulatory Surgical Centers
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Region
  • 4.2: North American Autologous Stem Cell and Non-Stem Cell Based Therapy Market
    • 4.2.1: North American Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application: Neurodegenerative Disorders, Autoimmune Diseases, Cancer & Tumors, and Cardiovascular Diseases
    • 4.2.2: North American Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use: Hospitals, Ambulatory Surgical Centers, and Others
  • 4.3: European Autologous Stem Cell and Non-Stem Cell Based Therapy Market
    • 4.3.1: European Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application: Neurodegenerative Disorders, Autoimmune Diseases, Cancer & Tumors, and Cardiovascular Diseases
    • 4.3.2: European Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use: Hospitals, Ambulatory Surgical Centers, and Others
  • 4.4: APAC Autologous Stem Cell and Non-Stem Cell Based Therapy Market
    • 4.4.1: APAC Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application: Neurodegenerative Disorders, Autoimmune Diseases, Cancer & Tumors, and Cardiovascular Diseases
    • 4.4.2: APAC Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use: Hospitals, Ambulatory Surgical Centers, and Others
  • 4.5: ROW Autologous Stem Cell and Non-Stem Cell Based Therapy Market
    • 4.5.1: ROW Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application: Neurodegenerative Disorders, Autoimmune Diseases, Cancer & Tumors, and Cardiovascular Diseases
    • 4.5.2: ROW Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use: Hospitals, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Type
    • 6.1.3: Growth Opportunities for the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application
    • 6.1.4: Growth Opportunities for the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use
    • 6.1.5: Growth Opportunities for the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Region
  • 6.2: Emerging Trends in the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: BrainStorm Cell
  • 7.2: Cytori Therapeutics
  • 7.3: Dendreon Pharmaceuticals
  • 7.4: Novartis
  • 7.5: U.S. Stem Cell